1. Novel 15-Lipoxygenase-1 Inhibitor Protects Macrophages from Lipopolysaccharide-Induced Cytotoxicity

   Guo, H., Verhoek, I. C., Prins, G. G. H., van der Vlag, R., van der Wouden, P. E., van Merkerk, R., Quax, W. J., Olinga, P., Hirsch, A. K. H. & Dekker, F. J., 9-May-2019, In : Journal of Medicinal Chemistry. 62, 9, p. 4624-4637 14 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. A Pathophysiological Model of Non-Alcoholic Fatty Liver Disease Using Precision-Cut Liver Slices

   Prins, G. H., Luangmonkong, T., Oosterhuis, D., Mutsaers, H. A. M., Dekker, F. J. & Olinga, P., 27-Feb-2019, In : Nutrients. 11, 3, 14 p., 507.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Developing an Ex Vivo Non-Alcoholic Fatty Liver Disease Model Using Human Livers

   Prins, G., Oosterhuis, D., Van Wijk, L. A., Shelton, L. & Olinga, P., Oct-2018, In : Hepatology. 68, p. 1008A-1009A 2 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

4. On the toxicity and transport mechanisms of cisplatin in kidney tissues in comparison to a gold-based cytotoxic agent

   Spreckelmeyer, S., Estrada Ortiz, N., Prins, G., van der Zee, M., Gammelgaard, B., Sturup, S., de Graaf, I., Groothuis, G. M. M. & Casini, A., 2017, In : Metallomics. 9, p. 1786-1795 10 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (4) »